Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Wasley, A. AU - Alter, M. J. TI - Epidemiology of hepatitis C: geographic differences and temporal trends JO - Semin. Liver Dis. PY - 2000/// VL - 20 SP - 1 EP - 16 M3 - 10.1055/s-2000-9506 N1 - 10.1055/s-2000-9506 UR - http://dx.doi.org/10.1055/s-2000-9506 ER - TY - JOUR AU - Brown, R. S. AU - Gaglio, P. J. TI - Scope of worldwide hepatitis C problem JO - Liver Transpl. PY - 2003/// VL - 9 SP - S10 EP - S13 M3 - 10.1053/jlts.2003.50244 N1 - 10.1053/jlts.2003.50244 UR - http://dx.doi.org/10.1053/jlts.2003.50244 ER - TY - JOUR AU - Tomei, L. AU - Altamura, S. AU - Paonessa, G. AU - De Francesco, R. AU - Migliaccio, G. TI - HCV antiviral resistance: the impact of in vitro studies on the development of antiviral agents targeting the viral NS5B polymerase JO - Antiviral Chem. Chemother. PY - 2005/// VL - 16 SP - 225 EP - 245 ER - TY - JOUR AU - Urbani, A. TI - Substrate specificity of the hepatitis C virus serine protease NS3 JO - J. Biol. Chem. PY - 1997/// VL - 272 SP - 9204 EP - 9209 M3 - 10.1074/jbc.272.14.9204 N1 - 10.1074/jbc.272.14.9204 UR - http://dx.doi.org/10.1074/jbc.272.14.9204 ER - TY - JOUR AU - Yan, Y. TI - Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form JO - Protein Sci. PY - 1998/// VL - 7 SP - 837 EP - 847 ER - TY - JOUR AU - Kim, J. L. TI - Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide JO - Cell PY - 1996/// VL - 87 SP - 343 EP - 355 M3 - 10.1016/S0092-8674(00)81351-3 N1 - 10.1016/S0092-8674(00)81351-3 UR - http://dx.doi.org/10.1016/S0092-8674(00)81351-3 ER - TY - JOUR AU - Love, R. A. TI - The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site JO - Cell PY - 1996/// VL - 87 SP - 331 EP - 342 M3 - 10.1016/S0092-8674(00)81350-1 N1 - 10.1016/S0092-8674(00)81350-1 UR - http://dx.doi.org/10.1016/S0092-8674(00)81350-1 ER - TY - JOUR AU - Llinas-Brunet, M. TI - Peptide-based inhibitors of the hepatitis C virus serine protease JO - Bioorg. Med. Chem. Lett. PY - 1998/// VL - 8 SP - 1713 EP - 1718 M3 - 10.1016/S0960-894X(98)00299-6 N1 - 10.1016/S0960-894X(98)00299-6 UR - http://dx.doi.org/10.1016/S0960-894X(98)00299-6 ER - TY - JOUR AU - Steinkuhler, C. TI - Product inhibition of the hepatitis C virus NS3 protease JO - Biochemistry PY - 1998/// VL - 37 SP - 8899 EP - 8905 M3 - 10.1021/bi980313v N1 - 10.1021/bi980313v UR - http://dx.doi.org/10.1021/bi980313v ER - TY - JOUR AU - Lamarre, D. TI - An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus JO - Nature PY - 2003/// VL - 426 SP - 186 EP - 189 M3 - 10.1038/nature02099 N1 - 10.1038/nature02099 UR - http://dx.doi.org/10.1038/nature02099 ER - TY - JOUR AU - Llinas-Brunet, M. TI - Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors JO - Bioorg. Med. Chem. Lett. PY - 2000/// VL - 10 SP - 2267 EP - 2270 M3 - 10.1016/S0960-894X(00)00465-0 N1 - 10.1016/S0960-894X(00)00465-0 UR - http://dx.doi.org/10.1016/S0960-894X(00)00465-0 ER - TY - JOUR AU - Goudreau, N. TI - NMR structural characterization of peptide inhibitors bound to the Hepatitis C virus NS3 protease: design of a new P2 substituent JO - J. Med. Chem. PY - 2004/// VL - 47 SP - 123 EP - 132 M3 - 10.1021/jm0303002 N1 - 10.1021/jm0303002 UR - http://dx.doi.org/10.1021/jm0303002 ER - TY - JOUR AU - Tsantrizos, Y. S. TI - Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection JO - Angew. Chem. Int. Ed. Engl. PY - 2003/// VL - 42 SP - 1356 EP - 1360 M3 - 10.1002/anie.200390347 N1 - 10.1002/anie.200390347 UR - http://dx.doi.org/10.1002/anie.200390347 ER - TY - JOUR AU - Hinrichsen, H. TI - Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients JO - Gastroenterology PY - 2004/// VL - 127 SP - 1347 EP - 1355 M3 - 10.1053/j.gastro.2004.08.002 N1 - 10.1053/j.gastro.2004.08.002 UR - http://dx.doi.org/10.1053/j.gastro.2004.08.002 ER - TY - JOUR AU - Reiser, M. TI - Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C JO - Hepatology PY - 2005/// VL - 41 SP - 832 EP - 835 M3 - 10.1002/hep.20612 N1 - 10.1002/hep.20612 UR - http://dx.doi.org/10.1002/hep.20612 ER - TY - JOUR AU - Lu, L. TI - Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro JO - Antimicrob. Agents Chemother. PY - 2004/// VL - 48 SP - 2260 EP - 2266 M3 - 10.1128/AAC.48.6.2260-2266.2004 N1 - 10.1128/AAC.48.6.2260-2266.2004 UR - http://dx.doi.org/10.1128/AAC.48.6.2260-2266.2004 ER - TY - JOUR AU - Lin, C. TI - In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms JO - J. Biol. Chem. PY - 2004/// VL - 279 SP - 17508 EP - 17514 M3 - 10.1074/jbc.M313020200 N1 - 10.1074/jbc.M313020200 UR - http://dx.doi.org/10.1074/jbc.M313020200 ER - TY - JOUR AU - Trozzi, C. TI - In vitro selection and characterization of hepatitis C virus serine protease variants resistant to an active-site peptide inhibitor JO - J. Virol. PY - 2003/// VL - 77 SP - 3669 EP - 3679 M3 - 10.1128/JVI.77.6.3669-3679.2003 N1 - 10.1128/JVI.77.6.3669-3679.2003 UR - http://dx.doi.org/10.1128/JVI.77.6.3669-3679.2003 ER - TY - JOUR AU - Thibeault, D. TI - Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor BILN 2061 JO - J. Virol. PY - 2004/// VL - 78 SP - 7352 EP - 7359 M3 - 10.1128/JVI.78.14.7352-7359.2004 N1 - 10.1128/JVI.78.14.7352-7359.2004 UR - http://dx.doi.org/10.1128/JVI.78.14.7352-7359.2004 ER - TY - JOUR AU - Chen, S. -H. TI - P1 and P1[prime] optimization of [3,4]-bicycloproline P2 incorporated tetrapeptidyl [alpha]-ketoamide based HCV protease inhibitors JO - Lett. Drug Des. Disc. PY - 2005/// VL - 2 SP - 118 EP - 123 M3 - 10.2174/1570180053175115 N1 - 10.2174/1570180053175115 UR - http://dx.doi.org/10.2174/1570180053175115 ER - TY - GEN TI - Vertex Pharmaceuticals reports that oral hepatitis C protease inhibitor VX-950 dramatically reduces viral levels in phase Ib clinical study PY - 2005/// ER - TY - JOUR AU - Lemon, S. M. AU - Yi, M. AU - Li, K. TI - Strong reasons make strong actions. The antiviral efficacy of NS3/4A protease inhibitors JO - Hepatology PY - 2005/// VL - 41 SP - 671 EP - 673 M3 - 10.1002/hep.20610 N1 - 10.1002/hep.20610 UR - http://dx.doi.org/10.1002/hep.20610 ER - TY - JOUR AU - Lin, C. TI - In vitro resistance mutations against VX-950 and BILN 2061, two protease inhibitor clinical candidates: single-resistance, cross-resistance and fitness JO - Hepatology PY - 2004/// VL - 40 SP - 404A EP - 404A ER - TY - JOUR AU - Behrens, S. E. AU - Tomei, L. AU - De Francesco, R. TI - Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus JO - EMBO J. PY - 1996/// VL - 15 SP - 12 EP - 22 ER - TY - JOUR AU - Ago, H. TI - Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus JO - Struct. Fold. Des. PY - 1999/// VL - 7 SP - 1417 EP - 1426 M3 - 10.1016/S0969-2126(00)80031-3 N1 - 10.1016/S0969-2126(00)80031-3 UR - http://dx.doi.org/10.1016/S0969-2126(00)80031-3 ER - TY - JOUR AU - Bressanelli, S. TI - Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus JO - Proc. Natl Acad. Sci. USA PY - 1999/// VL - 96 SP - 13034 EP - 13049 M3 - 10.1073/pnas.96.23.13034 N1 - 10.1073/pnas.96.23.13034 UR - http://dx.doi.org/10.1073/pnas.96.23.13034 ER - TY - JOUR AU - Lesburg, C. A. TI - Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site JO - Nature Struct. Biol. PY - 1999/// VL - 6 SP - 937 EP - 943 M3 - 10.1038/13305 N1 - 10.1038/13305 UR - http://dx.doi.org/10.1038/13305 ER - TY - JOUR AU - Biswal, B. K. TI - Crystal structures of the RNA dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors JO - J. Biol. Chem. PY - 2005/// VL - 280 SP - 18202 EP - 18210 M3 - 10.1074/jbc.M413410200 N1 - 10.1074/jbc.M413410200 UR - http://dx.doi.org/10.1074/jbc.M413410200 ER - TY - JOUR AU - Beaulieu, P. L. AU - Tsantrizos, Y. S. TI - Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections JO - Curr. Opin. Investig. Drugs PY - 2004/// VL - 5 SP - 838 EP - 850 ER - TY - GEN AU - Afdhal, N. TI - Final phase I/II trial results for NM283, a new polymerase inhibitor for hepatitis C: antiviral efficacy and tolerance in patients with HCV-1 infection, including previous interferon failures PY - 2004/// ER - TY - GEN AU - Standring, D. N. TI - NM283 has potent antiviral activity against chronic hepatitis C virus, genotype 1, in the chimpanzee PY - 2004/// ER - TY - JOUR AU - Carroll, S. TI - Susceptibility of different genotypes of hepatitis C virus to inhibition by nucleoside and nonnucleoside inhibitors JO - Antiviral Res. PY - 2004/// VL - 62 SP - A83 EP - A83 ER - TY - JOUR AU - Migliaccio, G. TI - Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro JO - J. Biol. Chem. PY - 2003/// VL - 278 SP - 49164 EP - 49170 M3 - 10.1074/jbc.M305041200 N1 - 10.1074/jbc.M305041200 UR - http://dx.doi.org/10.1074/jbc.M305041200 ER - TY - JOUR AU - Olsen, D. B. TI - A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties JO - Antimicrob. Agents Chemother. PY - 2004/// VL - 48 SP - 3944 EP - 3953 M3 - 10.1128/AAC.48.10.3944-3953.2004 N1 - 10.1128/AAC.48.10.3944-3953.2004 UR - http://dx.doi.org/10.1128/AAC.48.10.3944-3953.2004 ER - TY - GEN AU - Afdal, N. TI - Enhanced antiviral efficacy for Valopicitabine (NM283) plus peg-interferon in hepatitis C patients with HCV genotype-1 infection: Results of a phase IIa multicenter trial PY - 2005/// ER - TY - JOUR AU - Ludmerer, S. W. TI - Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay JO - Antimicrob. Agents Chemother. PY - 2005/// VL - 49 SP - 2059 EP - 2069 M3 - 10.1128/AAC.49.5.2059-2069.2005 N1 - 10.1128/AAC.49.5.2059-2069.2005 UR - http://dx.doi.org/10.1128/AAC.49.5.2059-2069.2005 ER - TY - GEN AU - Hashimoto, H. AU - Mizutani, K. AU - Yoshida, A. PY - 2001/// ER - TY - JOUR AU - LaPlante, S. R. TI - Binding mode determination of benzimidazole inhibitors of the hepatitis C virus RNA polymerase by a structure and dynamics strategy JO - Angew Chem. Int. Ed. Engl. PY - 2004/// VL - 43 SP - 4306 EP - 4311 M3 - 10.1002/anie.200460326 N1 - 10.1002/anie.200460326 UR - http://dx.doi.org/10.1002/anie.200460326 ER - TY - JOUR AU - Tomei, L. TI - Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase JO - J. Virol. PY - 2003/// VL - 77 SP - 13225 EP - 13231 M3 - 10.1128/JVI.77.24.13225-13231.2003 N1 - 10.1128/JVI.77.24.13225-13231.2003 UR - http://dx.doi.org/10.1128/JVI.77.24.13225-13231.2003 ER - TY - JOUR AU - Di Marco, S. TI - Interdomain communication in hepatitis C virus polymerase abolished by small-molecule inhibitors bound to a novel allosteric site JO - J. Biol. Chem. PY - 2005/// SP - EP - M3 - 10.1074/jbc.M505423200 N1 - 10.1074/jbc.M505423200 UR - http://dx.doi.org/10.1074/jbc.M505423200 ER - TY - GEN AU - Lu, H. PY - 2005/// ER - TY - GEN TI - Poor bioavailability results in insignificant clinical effects for Rigel R803 in phase I/II HCV trial PY - 2004/// ER - TY - GEN TI - ViroPharma announces data from HCV-086 proof of concept study PY - 2005/// ER - TY - JOUR AU - Chan, L. TI - Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: tertiary amides JO - Bioorg. Med. Chem. Lett. PY - 2004/// VL - 14 SP - 797 EP - 800 M3 - 10.1016/j.bmcl.2003.10.068 N1 - 10.1016/j.bmcl.2003.10.068 UR - http://dx.doi.org/10.1016/j.bmcl.2003.10.068 ER - TY - JOUR AU - Chan, L. TI - Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides JO - Bioorg. Med. Chem. Lett. PY - 2004/// VL - 14 SP - 793 EP - 796 M3 - 10.1016/j.bmcl.2003.10.067 N1 - 10.1016/j.bmcl.2003.10.067 UR - http://dx.doi.org/10.1016/j.bmcl.2003.10.067 ER - TY - JOUR AU - Wang, M. TI - Non-nucleoside analogue inhibitors bind to an allosteric site on HCV NS5B polymerase. Crystal structures and mechanism of inhibition JO - J. Biol. Chem. PY - 2003/// VL - 278 SP - 9489 EP - 9495 M3 - 10.1074/jbc.M209397200 N1 - 10.1074/jbc.M209397200 UR - http://dx.doi.org/10.1074/jbc.M209397200 ER - TY - JOUR AU - Love, R. A. TI - Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme JO - J. Virol. PY - 2003/// VL - 77 SP - 7575 EP - 7581 M3 - 10.1128/JVI.77.13.7575-7581.2003 N1 - 10.1128/JVI.77.13.7575-7581.2003 UR - http://dx.doi.org/10.1128/JVI.77.13.7575-7581.2003 ER - TY - JOUR AU - Dhanak, D. TI - Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase JO - J. Biol. Chem. PY - 2002/// VL - 277 SP - 38322 EP - 38327. M3 - 10.1074/jbc.M205566200 N1 - 10.1074/jbc.M205566200 UR - http://dx.doi.org/10.1074/jbc.M205566200 ER - TY - JOUR AU - Gu, B. TI - Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives JO - J. Biol. Chem. PY - 2003/// VL - 278 SP - 16602 EP - 16607 M3 - 10.1074/jbc.M210891200 N1 - 10.1074/jbc.M210891200 UR - http://dx.doi.org/10.1074/jbc.M210891200 ER - TY - JOUR AU - Tomei, L. TI - Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides JO - J. Virol. PY - 2004/// VL - 78 SP - 938 EP - 946 M3 - 10.1128/JVI.78.2.938-946.2004 N1 - 10.1128/JVI.78.2.938-946.2004 UR - http://dx.doi.org/10.1128/JVI.78.2.938-946.2004 ER - TY - JOUR AU - Nguyen, T. T. TI - Resistance profile of a hepatitis C virus RNA-dependent RNA polymerase benzothiadiazine inhibitor JO - Antimicrob. Agents Chemother. PY - 2003/// VL - 47 SP - 3525 EP - 3530 M3 - 10.1128/AAC.47.11.3525-3530.2003 N1 - 10.1128/AAC.47.11.3525-3530.2003 UR - http://dx.doi.org/10.1128/AAC.47.11.3525-3530.2003 ER - TY - JOUR AU - Braasch, D. A. TI - Biodistribution of phosphodiester and phosphorothioate siRNA JO - Bioorg. Med. Chem. Lett. PY - 2004/// VL - 14 SP - 1139 EP - 1143 M3 - 10.1016/j.bmcl.2003.12.074 N1 - 10.1016/j.bmcl.2003.12.074 UR - http://dx.doi.org/10.1016/j.bmcl.2003.12.074 ER - TY - JOUR AU - Foster, G. R. TI - Past, present, and future hepatitis C treatments JO - Semin. Liver Dis. PY - 2004/// VL - 24 SP - 97 EP - 104 M3 - 10.1055/s-2004-832934 N1 - 10.1055/s-2004-832934 UR - http://dx.doi.org/10.1055/s-2004-832934 ER - TY - JOUR AU - Kronke, J. TI - Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs JO - J. Virol. PY - 2004/// VL - 78 SP - 3436 EP - 3446 M3 - 10.1128/JVI.78.7.3436-3446.2004 N1 - 10.1128/JVI.78.7.3436-3446.2004 UR - http://dx.doi.org/10.1128/JVI.78.7.3436-3446.2004 ER - TY - JOUR AU - Kapadia, S. B. AU - Brideau-Andersen, A. AU - Chisari, F. V. TI - Interference of hepatitis C virus RNA replication by short interfering RNAs JO - Proc. Natl Acad Sci USA PY - 2003/// VL - 100 SP - 2014 EP - 2018 M3 - 10.1073/pnas.252783999 N1 - 10.1073/pnas.252783999 UR - http://dx.doi.org/10.1073/pnas.252783999 ER - TY - JOUR AU - Yokota, T. TI - Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs JO - EMBO Rep. PY - 2003/// VL - 4 SP - 602 EP - 608 M3 - 10.1038/sj.embor.embor840 N1 - 10.1038/sj.embor.embor840 UR - http://dx.doi.org/10.1038/sj.embor.embor840 ER - TY - JOUR AU - Wilson, J. A. TI - RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells JO - Proc. Natl Acad. Sci. USA PY - 2003/// VL - 100 SP - 2783 EP - 2788 M3 - 10.1073/pnas.252758799 N1 - 10.1073/pnas.252758799 UR - http://dx.doi.org/10.1073/pnas.252758799 ER - TY - JOUR AU - Randall, G. AU - Grakoui, A. AU - Rice, C. M. TI - Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs JO - Proc. Natl Acad. Sci. USA PY - 2003/// VL - 100 SP - 235 EP - 240 M3 - 10.1073/pnas.0235524100 N1 - 10.1073/pnas.0235524100 UR - http://dx.doi.org/10.1073/pnas.0235524100 ER - TY - JOUR AU - Song, E. TI - RNA interference targeting Fas protects mice from fulminant hepatitis JO - Nature Med. PY - 2003/// VL - 9 SP - 347 EP - 351 M3 - 10.1038/nm828 N1 - 10.1038/nm828 UR - http://dx.doi.org/10.1038/nm828 ER - TY - JOUR AU - Zender, L. TI - Caspase 8 small interfering RNA prevents acute liver failure in mice JO - Proc. Natl Acad. Sci. USA PY - 2003/// VL - 100 SP - 7797 EP - 7802 M3 - 10.1073/pnas.1330920100 N1 - 10.1073/pnas.1330920100 UR - http://dx.doi.org/10.1073/pnas.1330920100 ER - TY - JOUR AU - McCaffrey, A. P. TI - RNA interference in adult mice JO - Nature PY - 2002/// VL - 418 SP - 38 EP - 39 M3 - 10.1038/418038a N1 - 10.1038/418038a UR - http://dx.doi.org/10.1038/418038a ER - TY - GEN AU - Han, J. TI - Inhibition of HCV replication in vivo by nuclease-resistant siRNAs that are targeted to the liver PY - 2004/// ER - TY - JOUR AU - Wilson, J. A. AU - Richardson, C. D. TI - Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region JO - J. Virol. PY - 2005/// VL - 79 SP - 7050 EP - 8 M3 - 10.1128/JVI.79.11.7050-7058.2005 N1 - 10.1128/JVI.79.11.7050-7058.2005 UR - http://dx.doi.org/10.1128/JVI.79.11.7050-7058.2005 ER - TY - GEN TI - Benitec announces clinical candidate for treatment of hepatitis C PY - 2005/// ER - TY - JOUR AU - O'Neill, L. A. TI - TLRs: Professor Mechnikov, sit on your hat JO - Trends Immunol. PY - 2004/// VL - 25 SP - 687 EP - 693 M3 - 10.1016/j.it.2004.10.005 N1 - 10.1016/j.it.2004.10.005 UR - http://dx.doi.org/10.1016/j.it.2004.10.005 ER - TY - JOUR AU - Takeda, K. AU - Kaisho, T. AU - Akira, S. TI - Toll-like receptors JO - Annu. Rev. Immunol. PY - 2003/// VL - 21 SP - 335 EP - 376 M3 - 10.1146/annurev.immunol.21.120601.141126 N1 - 10.1146/annurev.immunol.21.120601.141126 UR - http://dx.doi.org/10.1146/annurev.immunol.21.120601.141126 ER - TY - JOUR AU - Boehme, K. W. AU - Compton, T. TI - Innate sensing of viruses by toll-like receptors JO - J. Virol. PY - 2004/// VL - 78 SP - 7867 EP - 7873 M3 - 10.1128/JVI.78.15.7867-7873.2004 N1 - 10.1128/JVI.78.15.7867-7873.2004 UR - http://dx.doi.org/10.1128/JVI.78.15.7867-7873.2004 ER - TY - JOUR AU - Iwasaki, A. AU - Medzhitov, R. TI - Toll-like receptor control of the adaptive immune responses JO - Nature Immunol. PY - 2004/// VL - 5 SP - 987 EP - 995 M3 - 10.1038/ni1112 N1 - 10.1038/ni1112 UR - http://dx.doi.org/10.1038/ni1112 ER - TY - JOUR AU - Hahn, Y. S. TI - Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion? JO - Curr. Opin. Immunol. PY - 2003/// VL - 15 SP - 443 EP - 449 M3 - 10.1016/S0952-7915(03)00076-1 N1 - 10.1016/S0952-7915(03)00076-1 UR - http://dx.doi.org/10.1016/S0952-7915(03)00076-1 ER - TY - JOUR AU - McKenna, K. AU - Beignon, A. S. AU - Bhardwaj, N. TI - Plasmacytoid dendritic cells: linking innate and adaptive immunity JO - J. Virol. PY - 2005/// VL - 79 SP - 17 EP - 27 M3 - 10.1128/JVI.79.1.17-27.2005 N1 - 10.1128/JVI.79.1.17-27.2005 UR - http://dx.doi.org/10.1128/JVI.79.1.17-27.2005 ER - TY - JOUR AU - Schetter, C. AU - Vollmer, J. TI - Toll-like receptors involved in the response to microbial pathogens: development of agonists for toll-like receptor 9 JO - Curr. Opin. Drug Discov. Dev. PY - 2004/// VL - 7 SP - 204 EP - 210 ER - TY - GEN TI - Coley reports results from phase I studies of Actilon[trade] for hepatitis C PY - 2005/// ER - TY - JOUR AU - Lee, J. TI - Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7 JO - Proc. Natl Acad. Sci. USA PY - 2003/// VL - 100 SP - 6646 EP - 6651 M3 - 10.1073/pnas.0631696100 N1 - 10.1073/pnas.0631696100 UR - http://dx.doi.org/10.1073/pnas.0631696100 ER - TY - JOUR AU - Horsmans, Y. TI - Isatoribine a Toll-like receptor 7 agonist, significantly reduced plasma viral load in a clinical proof-of-concept study in patients with chronic hepatitis C virus JO - Hepatology PY - 2004/// VL - 40 SP - 282A EP - 282A ER - TY - GEN TI - Anadys Pharmaceuticals announces selection of ANA975 as a development candidate for front-line treatment of chronic hepatitis C PY - 2004/// ER - TY - JOUR AU - Hannon, G. J. TI - RNA interference JO - Nature PY - 2002/// VL - 418 SP - 244 EP - 251 M3 - 10.1038/418244a N1 - 10.1038/418244a UR - http://dx.doi.org/10.1038/418244a ER - TY - JOUR AU - Elbashir, S. M. TI - Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells JO - Nature PY - 2001/// VL - 411 SP - 494 EP - 498 M3 - 10.1038/35078107 N1 - 10.1038/35078107 UR - http://dx.doi.org/10.1038/35078107 ER - TY - JOUR AU - Manoharan, M. TI - RNA interference and chemically modified small interfering RNAs JO - Curr. Opin. Chem. Biol. PY - 2004/// VL - 8 SP - 570 EP - 579 M3 - 10.1016/j.cbpa.2004.10.007 N1 - 10.1016/j.cbpa.2004.10.007 UR - http://dx.doi.org/10.1016/j.cbpa.2004.10.007 ER -